NVS - Celldex upgraded at Wells Fargo; says competitive headwinds priced in
2023-11-10 12:14:28 ET
More on Celldex
- Celldex: Mast Cell Disease Targeting Continues To Make Advancements In Clinic
- Celldex Therapeutics announces pricing of public offering of common stock
- Celldex Therapeutics announces proposed public offering of common stock
- Seeking Alpha’s Quant Rating on Celldex
- Historical earnings data for Celldex
For further details see:
Celldex upgraded at Wells Fargo; says competitive headwinds priced in